Gerresheimer announced plans to build its first medical plastic systems and syringes manufacturing facility in Skopje, North Macedonia, in March 2019, as part of its growth strategy.

The new facility will manufacture glass pre-fillable syringes and plastic drug delivery systems for both the pharmaceutical and healthcare sectors. It will add additional manufacturing capacity to Gerresheimer’s production network in Europe.

The development of the new plant will be carried out in five phases, with the first phase expected to generate employment for up to 400 people in engineer, computer scientist, and electrical engineer roles.

Construction on phase one will be commenced in the first half of 2019 and is expected to be completed by the first half of 2020. The new facility is anticipated to start production in the second half of 2020.


The medical plastic systems and syringes facility is located within the 96.75ha Skopje 2 free economic zone in Ilinden municipality. The site is 4.6km away from the E-75 highway and 10km east of Skopje.

The greenfield site has been selected as the ideal location for the proposed packaging plant for its close proximity to Skopje International Airport and major transport links.

Gerresheimer’s medical plastic systems and syringes facility details

The new medical plastic systems and syringes plant will be operated by the Medical Systems business unit of Gerresheimer’s Plastics & Devices division, while its construction and production activities will be supported by the competence centre in Wackersdorf.

“The new facility is anticipated to start production in the second half of 2020.”

The company’s Pfreimd and Buende plants in Germany, as well as the Horsovsky Tyn facility in the Czech Republic, will support the construction of the new plant.

The first phase of construction will involve the installation of plastic systems production lines for medical, diagnostic, and drug delivery products.

Pre-fillable glass syringes lines will be added in the future phases to manufacture standard and customised glass product solutions for filling medications.

The plant will be outfitted with a camera inspection system to eliminate defects of glass syringes and accelerate product verification.

Products manufactured at the new facility

The new plant will manufacture safe and easy-to-use medical plastic systems such as powder and capsule inhalers, insulin pens, lancets, auto-injectors, point-of-care devices, laboratory disposables, and other diagnostic systems.

It will produce a variety of pre-fillable glass syringes with filling volumes from 0.5ml to 5ml. The product range includes Gx® pre-fillable needle glass syringes, Gx® pre-fillable Luer lock glass syringes, and Gx® pre-fillable Luer cone glass syringes.

The syringes will be equipped with backstop, plunger stopper, and plunger rod and will be delivered as a complete system in bulk (Gx® bulk) or in ready-to-fill format.

Marketing commentary on Gerresheimer

Headquartered in Düsseldorf, Germany, Gerresheimer manufactures speciality glass and plastic pharmaceutical packaging, drug delivery devices, medical, and diagnostic products for pharma and healthcare applications.

Gerresheimer’s pharmaceutical packaging product portfolio comprises pre-fillable syringes, inhalers, insulin pens, ampules, injection vials, micropumps, bottles, and containers for liquid and solid medicines.

The company also produces glass and plastic packaging for cosmetics, fragrances, nutritional supplements, as well as the food and beverage industry.

Gerresheimer operates approximately 40 production plants with up to 10,000 employees in 15 countries worldwide. It reported revenues of approximately €1.4bn ($1.59bn) in 2018.